MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

DownloadDownload image
Cash and cashequivalents$14,948K Prepaid expenses andother current assets$1,252K Total current assets$16,200K Operating lease,right-of-use assets$4,539K Other long-termprepaid assets$995K Restricted cash,noncurrent$706K Property and equipment,net$249K Total assets$22,689K Accumulated deficit-$245,495K Treasury stock, at cost,14,455 shares...$150K Accumulated othercomprehensive loss-$122K Total liabilities andstockholders equity...$22,689K Total stockholders'(deficit) equity-$1,437K Additional paid-in capital$244,144K Common stock, 0.01 parvalue per share...$186K Total liabilities$24,126K Long-term debt, net$9,475K Total currentliabilities$7,229K Operating leaseliability, noncurrent$3,823K Warrant liabilities$3,599K Accrued expenses$5,915K Operating leaseliability, current$1,042K Accounts payable$272K
Balance Sheet

Elicio Therapeutics, Inc. (ELTX)

Elicio Therapeutics, Inc. (ELTX)

source: myfinsight.com